Table 3.
Parameter | Selected for analyses |
---|---|
Period of reported results (minimum follow-up period) | (i) BOLT: 18-month update (18 months of follow-up) (ii) ERIVANCE: 12-month update (21 months of follow-up) |
| |
Efficacy outcomes | (i) ORR (ii) DOR (iii) PFS |
| |
Matching variables | (i) Prior BCC radiotherapy (ii) Prior BCC surgery |
BCC: basal cell carcinoma; DOR: duration of response; ORR: objective response rate; PFS: progression-free survival.